This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción DBD
Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Diebold Nixdorf, Incorporated
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.05 |
| 52 Week High | US$4.02 |
| 52 Week Low | US$0.01 |
| Beta | 0 |
| 1 Month Change | 21.95% |
| 3 Month Change | -84.62% |
| 1 Year Change | -98.60% |
| 3 Year Change | -99.26% |
| 5 Year Change | -98.70% |
| Change since IPO | -99.88% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| DBD | DE Tech | Mercado DE | |
|---|---|---|---|
| 7D | 0% | -13.0% | -1.5% |
| 1Y | -98.6% | -63.9% | 0.9% |
Rentabilidad vs. Industria: DBD underperformed the German Tech industry which returned -37.5% over the past year.
Rentabilidad vs. Mercado: DBD underperformed the German Market which returned 3% over the past year.
Volatilidad de los precios
| DBD volatility | |
|---|---|
| DBD Average Weekly Movement | 86.4% |
| Tech Industry Average Movement | 14.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: DBD's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: DBD's weekly volatility has increased from 45% to 86% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1859 | 21,000 | Octavio Marquez | www.dieboldnixdorf.com |
Resumen de fundamentos de Diebold Nixdorf, Incorporated
| Estadísticas fundamentales de DBD | |
|---|---|
| Capitalización bursátil | €670.39m |
| Beneficios(TTM) | -€907.92m |
| Ingresos (TTM) | €3.27b |
0.2x
Ratio precio-ventas (PS)-0.7x
Ratio precio-beneficio (PE)¿Está DBD sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DBD | |
|---|---|
| Ingresos | US$3.56b |
| Coste de los ingresos | US$2.70b |
| Beneficio bruto | US$858.20m |
| Otros gastos | US$1.85b |
| Beneficios | -US$987.30m |
Últimos beneficios comunicados
Jun 30, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -26.33 |
| Margen bruto | 24.11% |
| Margen de beneficio neto | -27.74% |
| Ratio deuda/patrimonio | -59.0% |
¿Cómo se ha desempeñado DBD a largo plazo?
Ver rendimiento histórico y comparativa